Literature DB >> 11212885

Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18.

H A Cubie1, A L Seagar, E McGoogan, J Whitehead, A Brass, M J Arends, M W Whitley.   

Abstract

AIMS: To assess the validity and practicality of real time polymerase chain reaction (PCR) for human papillomavirus (HPV) testing in combination with liquid based cytology samples for cervical screening.
METHODS: Real time PCR using consensus (GPS+/6+) and type specific primers was developed to detect genital HPV types. This provides rapid, efficient amplification followed by denaturation of the product and computer analysis of the kinetics data that are generated. Liquid based cytology samples were obtained from patients attending routine cervical screening clinics. DNA was extracted from the residual cellular suspension after cytology using spin columns.
RESULTS: Real time PCR successfully distinguished between HPV-16 and HPV-18 on the basis of amplification with consensus primers followed by DNA melting temperature (Tm) analysis. Sensitivities of one to 10 copies of HPV-16 (mean Tm = 79.4 degrees C; 2 SD, 0.8) and four to 40 copies of HPV-18 (mean Tm = 80.4 degrees C; 2 SD, 0.4) were obtained. In a mixed population of SiHa and HeLa cells containing known copy numbers of HPV-16 and HPV-18 genomes, HPV-16 and HPV-18 products were clearly separated by Tm analysis in mixtures varying from equivalence to 111000. Together with detailed melt analysis, type specific primers from the same region of the L1 gene confirmed the differential ability of this system. The method was applied to 100 liquid based cytology samples where HPV status using conventional GP5+/6+ PCR was already known. There was 95% agreement between the methods, with 55 positives detected by conventional PCR and 59 with real time PCR. The method was then tested on 200 routine liquid based cytology samples. Approximately 10% were positive by real time PCR, most of which were classified as HPV-16 by detailed melt analysis. Thirteen (6.8%) HPV positives were identified in 189 samples showing no evidence of cervical cytological abnormality.
CONCLUSIONS: Real time PCR is a rapid, efficient method for the detection of HPV with the separation of HPV-16 and HPV-18 on the basis of differential Tm. Preliminary results suggest it could prove

Entities:  

Mesh:

Year:  2001        PMID: 11212885      PMCID: PMC1186996          DOI: 10.1136/mp.54.1.24

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  23 in total

1.  Amplification of human papillomavirus DNA sequences by using conserved primers.

Authors:  L Gregoire; M Arella; J Campione-Piccardo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR.

Authors:  M J Espy; J R Uhl; P S Mitchell; J N Thorvilson; K A Svien; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method.

Authors:  M J Arends; Y K Donaldson; E Duvall; A H Wyllie; C C Bird
Journal:  J Pathol       Date:  1991-12       Impact factor: 7.996

4.  Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA.

Authors:  A Nitsche; N Steuer; C A Schmidt; O Landt; W Siegert
Journal:  Clin Chem       Date:  1999-11       Impact factor: 8.327

5.  ThinPrep Processor. Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens.

Authors:  D C Wilbur; E S Cibas; S Merritt; L P James; B M Berger; T A Bonfiglio
Journal:  Am J Clin Pathol       Date:  1994-02       Impact factor: 2.493

6.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression.

Authors:  R J Kurman; M H Schiffman; W D Lancaster; R Reid; A B Jenson; G F Temple; A T Lorincz
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661

8.  Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection.

Authors:  P J Snijders; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

9.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

10.  Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16.

Authors:  M J Arends; Y K Donaldson; E Duvall; A H Wyllie; C C Bird
Journal:  Hum Pathol       Date:  1993-04       Impact factor: 3.466

View more
  15 in total

1.  LightCycler multiplex PCR for the laboratory diagnosis of common viral infections of the central nervous system.

Authors:  S J Read; J L Mitchell; C G Fink
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland.

Authors:  C E Anderson; K M McLaren; F Rae; R J Sanderson; K S Cuschieri
Journal:  J Clin Pathol       Date:  2007-04       Impact factor: 3.411

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; G Gilkison; M J Arends; C Graham; E McGoogan
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

5.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

6.  Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.

Authors:  Stefania Bellone; Karim El-Sahwi; Emiliano Cocco; Francesca Casagrande; Marilisa Cargnelutti; Michela Palmieri; Eliana Bignotti; Chiara Romani; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

7.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; A L Seagar; M J Arends; C Moore; G Gilkisson; E McGoogan
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  Identification of HPV16-p16INK4a mediated methylation in oral potentially malignant disorder.

Authors:  Maria Rosa Buenahora; Gloria Inés Lafaurie; Sandra J Perdomo
Journal:  Epigenetics       Date:  2020-11-09       Impact factor: 4.528

9.  Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.

Authors:  Vasiliki Michopoulou; Stavros P Derdas; Emmanouil Symvoulakis; Nikolaos Mourmouras; Alexandros Nomikos; Dimitris Delakas; George Sourvinos; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2014-09-12

10.  Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.

Authors:  Hung N Luu; Karen Adler-Storthz; Laura M Dillon; Michele Follen; Michael E Scheurer
Journal:  Clin Med Insights Oncol       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.